North America contract research organization (CRO) market expected to reach $ 30.7B

DUBLIN–(BUSINESS WIRE)–The “North
America Contract Research Organization Market to 2025 – Regional
Analysis and Forecasts by Type; End User, and Country” report
has been added to ResearchAndMarkets.com’s offering.

The North America contract research organization (CRO) market is
expected to reach US$ 30,730.1 Mn in 2025 from US$ 16,369.3 Mn in 2017.
The market is estimated to grow with a CAGR of 8.4% from 2018-2025.

The growth of the contract research organization (CRO) market is
primarily attributed to the increasing R&D expenditures and outsourcing
activities and rise in the number of clinical trials. However, the
dearth of skilled professionals and regional competition in the CRO
services market are likely to pose a negative impact on the market
growth. On the other hand, growing biosimilars and biologics market and
increasing demand for specialized testing services are likely to have a
positive impact on the growth of the North America contract research
organization (CRO) market in the coming years.

Clinical trials are the crucial and significant step in discovering
whether the medical strategy, treatment, or device is safe and effective
for human use. The clinical studies help in understanding and
determining the best medical approaches for certain therapeutic area.
Clinical trials are conducted primarily to collect data regarding the
safety and efficacy of new drug and device development. Before the
approval of drug molecules and the medical devices by the regulatory
authorities, series of clinical studies are conducted.

Increasing prevalence of various communicable and non-communicable
diseases are increasing the demand for the development of new drugs or
medical devices for the treatment. This is in turn expected to increase
the demand of the clinical trial activities for various therapeutic
areas. As per the US National Library of Medicine presently
approximately, 280, 801 clinical studies have been listed with locations
of 50 states and 204 countries in till 2018. The number of registered
studies by August 2018, is shows the rise in the number of the
registration for the clinical trials.

In 2017, the clinical research services segment held a largest market
share of 54.5% of the contract research organization (CRO) market, by
type. This segment is also expected to dominate the market in 2025 owing
to increasing number of new drug molecules and medical devices for the
treatment of various therapeutic areas and the requirement for the
fulfillment of stringent regulatory requirements before product
approvals. Moreover, the laboratory services segment is anticipated to
witness the fastest growth rate of 10.5% during the forecast period,
2018 to 2025 owing to increasing number of clinical trials is expected
to rise in the coming near future.

North America contract research organization (CRO) market, based on the
end user was segmented into pharmaceutical & biotechnology companies and
medical devices companies. The pharmaceutical and biotechnology
companies segment is anticipated to grow at a CAGR of 8.2% during the
forecast period. Moreover, the medical device companies segment is
expected to grow at the fastest rate during the coming years.

Key Topics Covered:

Part 1. Introduction
1.1 Scope Of The Study
1.2
Report Guidance

Part 2. North America Contract Research Organization (CRO)
Market – Key Takeaways

Part 3. North America Contract Research Organization (CRO)
Market – Market Landscape
3.1 Overview
3.2 Market
Segmentation
3.3 Pest Analysis

Part 4. North America Contract Research Organization (CRO)
Market – Key Market Dynamics
4.1 Key Market Drivers
4.1.1
Increasing R&D Expenditures And Outsourcing Activities
4.1.2
Rise In The Number Of Clinical Trials
4.2 Key Market Restraints
4.2.1
Dearth Of Skilled Professionals
4.2.2 Regional Competition In The
CRO Services Market
4.3 Key Market Opportunities
4.3.1 Growing
Biosimilars And Biologics Market
4.3.2 Increasing Demand For
Specialized Testing Services
4.4 Future Trends
4.4.1
Increasing Market Consolidation
4.5 Impact Analysis

Part 5. Contract Research Organization (CRO) Market – North
America Analysis
5.1 North America Contract Research
Organization (CRO) Market Revenue Forecasts And Analysis
5.2 Market
Positioning
5.3 Performance Of Key Players
5.4 Expert Opinions

Part 6. North America Contract Research Organization (CRO)
Market Analysis – By Type
6.1 Overview
6.2 North
America Contract Research Organization (CRO) Market, By Type 2017 & 2025
(%)
6.3 North America Contract Research Organization (CRO) Market
Revenue And Forecasts To 2025, By Type (Us$ Mn)
6.4 Early Phase
Development Services Market
6.4.1 Overview
6.4.2 North America
Early Phase Development Services Market Revenue And Forecasts To 2025
(Us$ Mn)
6.4.3 Drug Discovery Services
6.4.4 Pre-Clinical
Services
6.5 Clinical Research Services
6.6 Laboratory Services
6.7
Post-Approval Services

Part 7. North America Contract Research Organization (CRO)
Market Analysis – By End User
7.1 Overview
7.2 North
America Contract Research Organization (CRO) Market, By End User, 2017 &
2025 (%)
7.3 North America Contract Research Organization (CRO)
Market Revenue And Forecasts To 2025, By End User (Us$ Mn)
7.4
Pharmaceutical And Biotechnology Companies
7.5 Medical Device
Companies

Part 8. North America Contract Research Organization (CRO)
Market Revenue And Forecasts To 2025

Part 9. Contract Research Organization (CRO) Market – Industry
Landscape
9.1 Overview
9.2 Growth Strategies In The
Contract Research Organization (CRO) Market, 2015-2018
9.3
Inorganic Growth Strategies
9.3.1 Overview
9.3.2 Merger &
Acquisitions
9.3.3 Collaborations
9.3.4 Partnership
9.3.5
Alliance
9.3.6 Agreement & Joint Venture
9.4 Organic
Growth Strategies
9.4.1 Overview
9.4.2 Launch
9.4.3
Expansion & Relocation
9.4.4 Enhancements

Part 10. Contract Research Organization (CRO) Market – Key
Company Profiles

• • IQVIA
  • Laboratory Corporation of America Holdings
  • PAREXEL International Corporation
  • ICON plc
  • Syneos Health
  • PRA Health Sciences
  • Charles River
  • Pharmaceutical Product Development, LLC
  • WuXi AppTec
  • Medpace

For more information about this report visit https://www.researchandmarkets.com/r/6l48c

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Biotechnology,
Drug
Discovery